Building a Fit for Purpose Clinical Trials Infrastructure to Accelerate the Assessment of Novel Hematopoietic Cell Transplantation Strategies and Cellular Immunotherapies

被引：6
|
作者：
Devine, Steven M. [1 ,2 ]
Horowitz, Mary M. [3 ,4 ]
机构：
[1] Natl Marrow Donor Program Be Match, 500 N 5th St, Minneapolis, MN 55401 USA
[2] Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA
[3] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA
[4] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI 53226 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 05期
关键词：
VERSUS-HOST-DISEASE; MARROW TRANSPLANTATION; NETWORK STATE; DOUBLE-BLIND; BONE-MARROW; BLOOD; LYMPHOMA; CYCLOPHOSPHAMIDE; THERAPY; CANCER;
D O I：
10.1200/JCO.20.01623
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：534 / +
页数：13
相关论文
共 5 条
  • [1] Cellular immunotherapy after autologous hematopoietic stem cell transplantation:: Experimental strategies and clinical experiences
    Abken, H
    Hombach, A
    Reinhard, G
    Märten, A
    Schlimper, C
    Glasmacher, A
    Bieber, T
    Schmidt-Wolf, IGH
    LEUKEMIA & LYMPHOMA, 2003, 44 (04) : 583 - 592
  • [2] ASSESSMENT OF CLINICAL SIGNIFICANCE OF NOVEL ALLELES FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION.
    Tian, Runying
    Hodges, Elaine
    Young, Candace
    DeOliveira, Angelica
    Wegner, Wendy E.
    Balgansuren, Gansuvd
    Chen, Dong-Feng
    HUMAN IMMUNOLOGY, 2014, 75 : 104 - 104
  • [3] The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation
    Alousi, Amin M.
    Anasetti, Claudio
    Antin, Joseph H.
    Appelbaum, Frederick R.
    Bashey, Asad
    Confer, Dennis L.
    Devine, Steven M.
    DiFronzo, Nancy
    Giralt, Sergio A.
    Grupp, Stephan N.
    Hari, Parameswaran N.
    Heslop, Helen E.
    Horowitz, Mary M.
    Jones, Richard J.
    Kurtzberg, Joanne
    Lazarus, Hillard M.
    Lowsky, Robert
    Mendizabal, Adam M.
    Merritt, William
    Nakamura, Ryotaro
    Pulsipher, Michael A.
    Ratanatharathorn, Voravit
    Stadtmauer, Edward A.
    Stiff, Patrick J.
    Vose, Julie M.
    Weisdorf, Daniel J.
    Westervelt, Peter
    Wingard, John R.
    Yanik, Gregory A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1747 - 1757
  • [4] Clinical Outcomes of Patients With Plasma Cell Leukemia in the Era of Novel Therapies and Hematopoietic Stem Cell Transplantation Strategies: A Single-Institution Experience
    Lebovic, Daniel
    Zhang, Ling
    Alsina, Melissa
    Nishihori, Taiga
    Shain, Kenneth H.
    Sullivan, Daniel
    Ochoa-Bayona, Jose L.
    Kharfan-Dabaja, Mohamed A.
    Baz, Rachid
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (06): : 507 - 511
  • [5] Circulating CD14+HLA-DR-/low myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease
    Yin, Jin
    Wang, Chunyan
    Huang, Min
    Mao, Xia
    Zhou, Jianfeng
    Zhang, Yicheng
    CANCER MEDICINE, 2016, 5 (07): : 1654 - 1669
1